InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Explore the detailed record of transactions filed by Kim Robert Young. Officer active across 1 company, notably 4D Molecular Therapeutics, Inc.. In total, 1 reports have been published. History available since 5 February 2024. The latest transaction was disclosed on 5 February 2024 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
1 of 1 declaration